Oramed to Present at World Diabetes Congress
NEW YORK, July 10, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that Dr. Miriam Kidron, Chief Scientific Officer of Oramed, will deliver two presentations at the World Diabetes Congress, being held July 15-17, 2019 in Rome, Italy. World […]
